Wenger Vieli Ltd acts for a variety of start-ups and global players in the pharma and medical device industries in mandates involving joint ventures, M&A, and disputes before the Federal Office of Public Health. In the Zurich office, practice head Frank Scherrer assists a range of biotech, medical device, and pharma companies on market access and establishment licences. Marcel Boller is particularly adept at advising on clinical research and distribution systems.
Legal 500 Editorial commentary
Work highlights
- Representing pharmaceutical companies in appeal proceedings regarding the price at which pharmaceutical products are reimbursed.
- Representing a pharmaceutical company in appeal proceedings regarding the deletion of one of its products from the list of reimbursed products.
- Advising a pharmaceutical company in Switzerland on ongoing legal reviews of all advertising and information materials.